Literature DB >> 10338046

Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset composition.

F C Marini1, S M Kornblau.   

Abstract

Allogeneic bone marrow transplant followed by donor lymphocyte infusion (DLI) is limited by T cell-mediated graft-versus-host disease (GVHD). A potential solution to alleviate uncontrolled GVHD is to create a controllable suicidal lymphocyte using retroviral transduction of the herpes simplex virus thymidine kinase gene (HSVtk) into the T cell graft. Should GVHD arise, the administration of ganciclovir (GCV) should eliminate the causal T cells. The culture conditions and expansion protocols required to produce suicidal lymphocytes may affect the composition of the T cell product. In this report we describe how T cells from individual donor samples respond to the same culture condition in highly varied ways. Among five donors, two demonstrated predominant expansion of CD4+ cells (with a decrease of CD8+), two donors resulted in predominately CD8+ cells, and one donor developed mainly dual positive CD8+/CD56+ cells. We observed a 20-fold expansion of T cells during the 14 day protocol. The function of the T cells was not affected by the transduction procedures (as tested by 51Cr release assays). In contrast to suicidal lymphocytes prepared using entire T cell populations, T cells pre-selected into CD3+/CD4+ or CD3+/CD8+ subpopulations prior to culture maintained their initial phenotype during the 14 day culture period, with little or no drift. Results from clinical trials using suicidal lymphocytes may be confounded by variance in lymphocyte subset compositions (LSC) and optimal use of suicidal lymphocytes may require separate culture and transduction to control the LSC delivered to the patient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338046     DOI: 10.1038/sj.bmt.1701738

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography.

Authors:  Amer M Najjar; Pallavi R Manuri; Simon Olivares; Leo Flores; Tiejuan Mi; Helen Huls; Elizabeth J Shpall; Richard E Champlin; Nashaat Turkman; Vincenzo Paolillo; Jason Roszik; Brian Rabinovich; Dean A Lee; Mian Alauddin; Juri Gelovani; Laurence J N Cooper
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

2.  Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.

Authors:  Carolina Berger; Mary E Flowers; Edus H Warren; Stanley R Riddell
Journal:  Blood       Date:  2005-11-10       Impact factor: 22.113

3.  Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.

Authors:  Steven M Kornblau; Preston G Aycox; Clifton Stephens; L David McCue; Richard E Champlin; Frank C Marini
Journal:  Exp Hematol       Date:  2007-05       Impact factor: 3.084

4.  Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis.

Authors:  Cecilia N Barese; Allen E Krouse; Mark E Metzger; Connor A King; Catia Traversari; Frank C Marini; Robert E Donahue; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2012-08-21       Impact factor: 11.454

5.  Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells.

Authors:  Nicolas Montcuquet; Patricia Mercier-Letondal; Sylvain Perruche; Anne Duperrier; Mélanie Couturier; Abdelghani Bouchekioua; Mark Bonyhadi; Christophe Ferrand; Pierre Tiberghien; Eric Robinet
Journal:  Immunology       Date:  2008-04-26       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.